NBSE logo

NeuBase Therapeutics, Inc. Common Stock


NBSE: NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.


Show NBSE Financials

Consumer Interest
SEC Filings

Recent trades of NBSE by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by NBSE's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Modified peptide nucleic acid compositions Mar. 14, 2023
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of NBSE in WallStreetBets Daily Discussion


Recent insights relating to NBSE

CNBC Recommendations

Recent picks made for NBSE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NBSE

Corporate Flights

Flights by private jets registered to NBSE